Laura G. Eichorn - Jan 3, 2023 Form 4 Insider Report for Imago BioSciences, Inc. (IMGO)

Signature
/s/ Hugh Rienhoff, as Attorney-in-fact for Laura Eichorn
Stock symbol
IMGO
Transactions as of
Jan 3, 2023
Transactions value $
$150,176
Form type
4
Date filed
1/5/2023, 03:29 PM
Previous filing
Dec 29, 2022
Next filing
Jan 11, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction IMGO Common Stock Options Exercise $57.8K +23K +10.96% $2.52* 232K Jan 3, 2023 Direct F1
transaction IMGO Common Stock Options Exercise $52.1K +12.4K +5.34% $4.20* 245K Jan 3, 2023 Direct
transaction IMGO Common Stock Options Exercise $40.3K +1.77K +0.72% $22.76 246K Jan 3, 2023 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction IMGO Stock Option (Right to Buy) Options Exercise $0 -23K -100% $0.00* 0 Jan 3, 2023 Common Stock 23K $2.52 Direct
transaction IMGO Stock Option (Right to Buy) Options Exercise $0 -12.4K -52.08% $0.00 11.4K Jan 3, 2023 Common Stock 12.4K $4.20 Direct F2
transaction IMGO Stock Option (Right to Buy) Options Exercise $0 -1.77K -1.72% $0.00 101K Jan 3, 2023 Common Stock 1.77K $22.76 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Reflects the adjusted total which includes the purchase of 1,597 shares under the Imago Employee Stock Purchase Plan on November 30, 2022.
F2 One forty-eighth (1/48th) of the shares initially subject to the option will vest on each monthly anniversary measured from November 12, 2020 (the "Vesting Commencement Date"), so that 100% of the shares subject to the option will be fully vested and exercisable as of the fourth anniversary of the Vesting Commencement Date, subject to the Reporting Person's continued service through each vesting date.
F3 25% of the shares subject to the option vest on the first anniversary measured from November 17, 2021 (the "Vesting Commencement Date"), and 1/48th of the total number of shares vest monthly thereafter, such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date.